Hyponatremic hypertensive syndrome secondary to renal ischemia – Case report
Hyponatremic hypertensive syndrome (HHS) is characterized by hypertensive crisis, and hyponatremia secondary to unilateral renal damage with glomerular and tubular dysfunction. Elevated plasma levels of renin in most cases suggest that the stimulation of renin release from the ischemic kidney plays an important pathophysiologic role. Activation of the renin-angiotensin system results in hypertension and causes secondary hyperfiltration, pressure diuresis and sodium loss from contralateral non-damaged kidney. An elevated renin level is a pathognomonic finding in HHS. Potassium deficiency from hyperaldosteronism may further stimulate renin secretion and intensify this vicious circle. We report a female term newborn, who presented with hypertensive crisis on the seventh day after traumatic birth. The first three days of life were uneventful. Initial treatment with captopril resulted in severe hypotension and hemodynamic instability. Lab work revealed hyponatremia, hypokalemia, and elevated peripheral renin activity and aldosterone levels. Complementary sonography and magnetic resonance confirmed right adrenal gland hematoma and several ischemic areas in the upper pole of the right kidney. The diagnosis of HHS secondary to renal ischemia was evoked. HHS is a rare condition in the neonatal period, though still under-recognized. In the neonatal and early infancy period, renovascular disease is the most common cause of secondary hypertension. In this case, there was no sign of vascular disease, the renin-angiotensin system was activated secondary to direct renal ischemia and infarction. The intense renin stimulation and pressure through the contralateral normal kidney results in high pressure natriuresis facilitating a severe volume-depleted state. Although the use of renin-angiotensin system inhibitors is the treatment of choice, it is imperative to re-establish hydration and renal perfusion before starting this antihypertensive medication. We aimed to improve awareness of HHS diagnosis and prompt treatment, to prevent continuous renal damage and other life-threatening complications..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2018 |
|---|---|
| Erschienen: |
2018 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:7 |
|---|---|
| Enthalten in: |
Journal of Pediatric and Neonatal Individualized Medicine - 7(2018), 1, Seite e070110-e070110 |
| Sprache: |
Englisch ; Italienisch |
|---|
| Beteiligte Personen: |
Joana Cunha Oliveira [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
Hypertension |
|---|
| doi: |
10.7363/070110 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ076510859 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ076510859 | ||
| 003 | DE-627 | ||
| 005 | 20230309143528.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 230228s2018 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.7363/070110 |2 doi | |
| 035 | |a (DE-627)DOAJ076510859 | ||
| 035 | |a (DE-599)DOAJ17261dfc7f3841219929fa09a9a2ab37 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng |a ita | ||
| 050 | 0 | |a RJ1-570 | |
| 100 | 0 | |a Joana Cunha Oliveira |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Hyponatremic hypertensive syndrome secondary to renal ischemia – Case report |
| 264 | 1 | |c 2018 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Hyponatremic hypertensive syndrome (HHS) is characterized by hypertensive crisis, and hyponatremia secondary to unilateral renal damage with glomerular and tubular dysfunction. Elevated plasma levels of renin in most cases suggest that the stimulation of renin release from the ischemic kidney plays an important pathophysiologic role. Activation of the renin-angiotensin system results in hypertension and causes secondary hyperfiltration, pressure diuresis and sodium loss from contralateral non-damaged kidney. An elevated renin level is a pathognomonic finding in HHS. Potassium deficiency from hyperaldosteronism may further stimulate renin secretion and intensify this vicious circle. We report a female term newborn, who presented with hypertensive crisis on the seventh day after traumatic birth. The first three days of life were uneventful. Initial treatment with captopril resulted in severe hypotension and hemodynamic instability. Lab work revealed hyponatremia, hypokalemia, and elevated peripheral renin activity and aldosterone levels. Complementary sonography and magnetic resonance confirmed right adrenal gland hematoma and several ischemic areas in the upper pole of the right kidney. The diagnosis of HHS secondary to renal ischemia was evoked. HHS is a rare condition in the neonatal period, though still under-recognized. In the neonatal and early infancy period, renovascular disease is the most common cause of secondary hypertension. In this case, there was no sign of vascular disease, the renin-angiotensin system was activated secondary to direct renal ischemia and infarction. The intense renin stimulation and pressure through the contralateral normal kidney results in high pressure natriuresis facilitating a severe volume-depleted state. Although the use of renin-angiotensin system inhibitors is the treatment of choice, it is imperative to re-establish hydration and renal perfusion before starting this antihypertensive medication. We aimed to improve awareness of HHS diagnosis and prompt treatment, to prevent continuous renal damage and other life-threatening complications. | ||
| 650 | 4 | |a hypertension | |
| 650 | 4 | |a hyponatremia | |
| 650 | 4 | |a hyponatremic hypertensive syndrome | |
| 650 | 4 | |a newborn | |
| 650 | 4 | |a renin-angiotensin system | |
| 650 | 4 | |a tubular dysfunction | |
| 653 | 0 | |a Medicine | |
| 653 | 0 | |a R | |
| 653 | 0 | |a Pediatrics | |
| 700 | 0 | |a Mariana Matos Martins |e verfasserin |4 aut | |
| 700 | 0 | |a Esmeralda Martins |e verfasserin |4 aut | |
| 700 | 0 | |a Gustavo Rocha |e verfasserin |4 aut | |
| 700 | 0 | |a Cláudia Moura |e verfasserin |4 aut | |
| 700 | 0 | |a Helena Pinto |e verfasserin |4 aut | |
| 700 | 0 | |a Ana Teixeira |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Journal of Pediatric and Neonatal Individualized Medicine |d Hygeia Press di Corridori Marinella, 2014 |g 7(2018), 1, Seite e070110-e070110 |w (DE-627)DOAJ000098175 |x 22810692 |7 nnns |
| 773 | 1 | 8 | |g volume:7 |g year:2018 |g number:1 |g pages:e070110-e070110 |
| 856 | 4 | 0 | |u https://doi.org/10.7363/070110 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/17261dfc7f3841219929fa09a9a2ab37 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.jpnim.com/index.php/jpnim/article/view/496 |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/2281-0692 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 7 |j 2018 |e 1 |h e070110-e070110 | ||